The results showed that STC2 inhibited the proliferation of breast cancer cells and promoted the apoptosis of TNBC cells by inhibiting the phosphorylation of Akt and reducing its phosphorylation level in TNBC cells, thereby blocking the Akt-related signalling pathway. Here, AKT1 is linked to breast carcinoma.